Brain Scientific Inc. (BRSF) Changing the Landscape by Tackling Neurology Deserts

  • Distribution of neurologists across the U.S. is uneven with 20 states experiencing neurology deserts
  • Brain Scientific has developed tools that help providers in neurology deserts provide access to neurological care
  • With explosion of telemedicine services and increased integration of advanced practice providers, neurologists’ shortage may improve

Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company, is directly tackling the shortage of neurologists in the United States with cutting-edge technologies. By creating cost-efficient, disposable and portable EEGs, BRSF makes neurology care more accessible without putting excess strain on the already overextended neurologist labor pool.

Between 2001 and 2016, the American Academy of Neurology (“AAN”) reported that out-of-pocket costs shot up substantially for privately insured patients. In addition, the distribution of neurologists across the U.S. is uneven, with patients in rural areas less likely to receive care ( There are 20 states, according to the 2017 Alzheimer’s Association International Conference, classified as neurology deserts ( This term designates an area that has projected a chronic shortage of neurologists alongside a rise in dementia cases.

“In many places, people do not have easy access to specialists, for a variety of reasons. But you may not need a neurologist in every case,” said Beth Kallmyer, MSW, vice president of Constituent Services at the Alzheimer’s Association. “With the right training and tools, primary care physicians can effectively diagnose and treat Alzheimer’s disease. The Alzheimer’s Association is working to arm primary care physicians with the tools they need to manage an increased caseload, as well as care planning guidance.”

Brain Scientific has developed tools that provide primary care physicians in neurology deserts the ability to serve their patients and create specialized treatment plans that provide access to neurologists. Portable, clinical-grade, easy-to-use diagnostic devices are now in place to allow to run EEG tests withing a few minutes. The company is actively working on a secure, cloud-based and highly scalable infrastructure to transmit patient data between neurologists and patients as well as creating artificial intelligence assisted diagnostic analysis.

Currently, across the United States, there is significant disparity between who has access to neurology care and who does not. A MedPate Today article reported that the lowest density had a mean of 9.7 neurologists for every 100,000 Medicare beneficiaries while the highest had 43.1 neurologists for every 100,000 ( While the number of conditions remained similar, the access to care did not. With the explosion of telemedicine services and an increased integration of advanced practice providers, neurologists’ shortage may just improve.

Through portable EEGs, teleneurology, on-demand data exchange and AI predictive biomarkers, Brain Scientific will create resources to narrow this wide gap. The company’s commercialized products were designed to disrupt the slow, expensive and cumbersome EEG market with easy-to-use, economical and disposable solutions. These devices are so easy to use that any medical professional can use them within minutes in any setting to run routine EEG studies.

Brain Scientific can potentially change the United States’ landscape and eliminate neurology deserts once and for all. It’s time everyone had access to the life-saving research available.

For more information, visit the company’s website at

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published:

BioMedWire (BMW)
San Francisco, California
415.949.5050 Office

BioMedWire is part of the InvestorBrandNetwork.


Select A Month

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts



Bitcoin Cash

Bitcoin Cash





USD Coin

USD Coin

Contact us: 415.949.5050